38LOW

VHL

VITASORA FPO [VHL]
Vitasora Health Limited researches, develops, and commercializes medical devices in Australia and the United States. It is also involved in the production of mobile health applications. The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025. The company is headquartered in Melbourne, Australia.
Healthcare · ASX Small Cap
$0.0220 +4.8%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical60
Catalyst51
Sentiment50
Fundamental48
Momentum45
Risk Gate45
Get alerts when VHL's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track VHL — Free

Active Signals

Bullish Signals

  • Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
  • Critical cash runway (1.1 quarters)
  • Moderate P/S ratio (8.5x)
  • Strong revenue growth (+84%)
  • Near 52-week low (14% of range)
  • Small-cap ($20-100M)
  • Capital raise activity (1 events)
  • CANSLIM I: Institutional ownership (11%)
  • Sentiment is mixed — no strong consensus either way
  • Revenue growing at +84% — the top line is moving in the right direction
  • Low-priced stock risk ($0.022)
  • Beneish M-Score 4.20 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Below the 200-day average — the long-term trend is still working against it
  • Deeply negative margins (-231%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 44% over the past year
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about VHL
"What's driving VHL's score?" "How does VHL compare to peers?" "Key risks for VHL?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

LOW Investor Presentation
NONE Notification of Investor Briefing
NONE Section 708A Cleansing Notice
NONE Application for quotation of securities - VHL

Recent ASX Announcements

2026-03-18 Investor Presentation
2026-03-15 Notification of Investor Briefing
2026-03-03 Section 708A Cleansing Notice
2026-03-03 Application for quotation of securities - VHL
2026-02-26 Appendix 4D and Half Year Financial Report PRICE SENSITIVE

Key Metrics

$42.7M
Market Cap
748K
Avg Volume
1.9x
Vol Ratio
$0.02 — $0.05
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-106.3%
ROE
-231.4%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 78%
LLeader vs LaggardlaggardRS: -1
IInstitutional SponsorshippassInst: 11%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #96 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:VHL vs ATXVHL vs PNVVHL vs IMM
Scout Pro — Deeper Analysis for VHL
Try Pro free for 30 days
Share this analysis

Track VHL and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required